Citius Pharmaceuticals- Warrants(02/08/2022) Total Liabilities

The latest total liabilities for CTXRW is $63M as of March 2026. That compares with $58M in the prior-year period — up 9.6% year over year. Investors often review this figure alongside Citius Pharmaceuticals- Warrants(02/08/2022)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CTXRW's total liabilities moved from $58M to $63M — a 9.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Citius Pharmaceuticals- Warrants(02/08/2022)'s operating scale or balance-sheet position.

A total liabilities figure of $63M for CTXRW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CTXRW's total liabilities ($63M), review year-over-year change from $58M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Citius Pharmaceuticals- Warrants(02/08/2022)'s total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.